LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR‐9‐5p/QKI‐5 axis

This study was designed to detecting the influences of lncRNA MEG3 in prostate cancer. Aberrant lncRNAs expression profiles of prostate cancer were screened by microarray analysis. The qRT‐PCR and Western blot were employed to investigating the expression levels of lncRNA MEG3, miR‐9‐5p and QKI‐5. The luciferase reporter assay was utilized to testifying the interactions relationship among these molecules. Applying CCK‐8 assay, wound healing assay, transwell assay and flow cytometry in turn, the cell proliferation, migration and invasion abilities as well as apoptosis were measured respectively. LncRNA MEG3 was a down‐regulated lncRNA in prostate cancer tissues and cells and could inhibit the expression of miR‐9‐5p, whereas miR‐9‐5p down‐regulated QKI‐5 expression. Overexpressed MEG3 and QKI‐5 could decrease the abilities of proliferation, migration and invasion in prostate cancer cells effectively and increased the apoptosis rate. On the contrary, miR‐9‐5p mimics presented an opposite tendency in prostate cancer cells. Furthermore, MEG3 inhibited tumour growth and up‐regulated expression of QKI‐5 in vivo. LncRNA MEG3 was a down‐regulated lncRNA in prostate cancer and impacted the abilities of cell proliferation, migration and invasion, and cell apoptosis rate, this regulation relied on regulating miR‐9‐5p and its targeting gene QKI‐5.

[1]  T. Jiang,et al.  SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer. , 2017, Biochemical and biophysical research communications.

[2]  Xiaozhou He,et al.  LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway , 2016, Tumor Biology.

[3]  Yangjian,et al.  Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. , 2017 .

[4]  Jia Wen Liang,et al.  Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer , 2017, Molecular Cancer Research.

[5]  X. Wang,et al.  lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. , 2017, European review for medical and pharmacological sciences.

[6]  Tongyu Ji,et al.  Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. , 2017, American journal of translational research.

[7]  V. Conteduca,et al.  Urinary RNA-based biomarkers for prostate cancer detection. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[8]  Guosong Jiang,et al.  Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer , 2015, Cellular Physiology and Biochemistry.

[9]  Jie Zan,et al.  miR-29a promotes scavenger receptor A expression by targeting QKI (quaking) during monocyte-macrophage differentiation. , 2015, Biochemical and biophysical research communications.

[10]  X. Fu,et al.  QKI-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway. , 2015, International journal of oral and maxillofacial surgery.

[11]  C. Xie,et al.  Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression , 2016, Tumor Biology.

[12]  Li Wang,et al.  Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software , 2017, J. Comput. Biol..

[13]  Shumei Ma,et al.  Hsp90 regulates autophagy and plays a role in cancer therapy , 2015, Tumor Biology.

[14]  Lei Fang,et al.  LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR‐146a , 2016, Cancer medicine.

[15]  Dan Wang,et al.  An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation , 2017, PloS one.

[16]  C. Zhu,et al.  Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway , 2017, Oncotarget.

[17]  Jing Chen,et al.  MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial–mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma , 2016, Molecular Cancer.

[18]  Jun Xue,et al.  Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. , 2017, Gene.

[19]  Zeping Han,et al.  Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells , 2016, Tumor Biology.

[20]  Xiaobin Lv,et al.  Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184 , 2017, Oncotarget.

[21]  Wei-bo Xu,et al.  Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  Jia Yu,et al.  Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression , 2015, Journal of experimental & clinical cancer research : CR.

[23]  W. Lu,et al.  The tumor suppressing effects of QKI-5 in prostate cancer , 2014, Cancer biology & therapy.